Issue link: https://read.dmtmag.com/i/1535169
30 tobaccoasia Issue 3, 2025 May / June SPONSORED CONTENT Donald Trump's inconsistent track-record on reduced risk nicotine products (RRPs) may leave spectators asking what his second term could bring for tobacco and nicotine product regulation in the USA. In 2019, Trump promised to ban flavored vape products 'to protect children', but subsequently reversed his position, highlighting the need for these products to help adults quit smoking. In the run up to the 2024 presidential election, Trump posted on Truth Social "I saved flavored vaping in 2019, and it greatly helped people get off smoking" and "I'll save vaping again." With control of the house, senate and presidency, and a super-majority of Samuel C. Hampsher-Monk VP, Global Regulatory Strategy & Business Operations Applied Research and Analysis Company SAMUEL C. HAMPSHER-MONK {BIO} Samuel 'Sam' Hampsher-Monk joined ARAC in January 2025 as VP, Global Regulatory Strategy and Business Operations, having spent seven years as Managing Director of BOTEC Analysis where he led inter- national, multidisciplinary research on cannabis, tobacco, and nicotine prod- uct regulation for state and municipal agencies, research institutions, and philanthropic foundations. He has authored technical reports, case stud- ies, white papers, policy briefs, and academic papers on topics such as consumer product regulation, taxa- tion, illicit trade, policy reform, and social justice. His peer-reviewed research has been published in the Journal of Consumer Policy and the Journal of Health Communication. He is also the lead author of Clearing the Air on E-Cigarettes and Harm Reduc- tion: Tobacco Control, Economics, and Public Health (Palgrave Macmil- lan, 2024). About Applied Research and Analysis Company (ARAC): Applied Research and Analysis Company (ARAC) is a leading U.S.- based, global behavioral science re- search firm that designs, executes, and presents studies to support manufacturers, regulatory agencies, and industry consultants in their PMTAs, MRTPAs, and SEs. Their expertise also includes consumer- focused research services in prod- uct development and innovation. ARAC specializes in MODULE 5 & 6 studies including: label/claim development and comprehension, human factors/usability testing, and clinical/behavioral studies, such as switching studies to assess the benefit to the U.S. population, including randomized experimental longitudinal, actual use, and cohort studies, Tobacco Product Percep- tions and Intentions (TPPI), and post-market surveillance systems. Learn more: ARACscience.com How Will Tobacco and Nicotine Regulations Fare in the New US Admin?